Malaysia · Delayed Price · Currency is MYR KLSE:HSPLANT Statistics
Total Valuation
KLSE:HSPLANT has a market cap or net worth of MYR 1.63 billion. The enterprise value is 1.04 billion.
| Market Cap | 1.63B |
| Enterprise Value | 1.04B |
Important Dates
The last earnings date was Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | Sep 11, 2025 |
Share Statistics
KLSE:HSPLANT has 799.69 million shares outstanding.
| Current Share Class | 799.69M |
| Shares Outstanding | 799.69M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 9.45% |
| Float | 212.39M |
Valuation Ratios
The trailing PE ratio is 9.09 and the forward PE ratio is 10.79.
| PE Ratio | 9.09 |
| Forward PE | 10.79 |
| PS Ratio | 2.21 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | 9.47 |
| P/OCF Ratio | 6.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.23, with an EV/FCF ratio of 6.06.
| EV / Earnings | 5.81 |
| EV / Sales | 1.41 |
| EV / EBITDA | 3.23 |
| EV / EBIT | 4.41 |
| EV / FCF | 6.06 |
Financial Position
The company has a current ratio of 10.37, with a Debt / Equity ratio of 0.03.
| Current Ratio | 10.37 |
| Quick Ratio | 8.41 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.34 |
| Interest Coverage | 77.86 |
Financial Efficiency
Return on equity (ROE) is 8.73% and return on invested capital (ROIC) is 6.98%.
| Return on Equity (ROE) | 8.73% |
| Return on Assets (ROA) | 5.79% |
| Return on Invested Capital (ROIC) | 6.98% |
| Return on Capital Employed (ROCE) | 9.41% |
| Revenue Per Employee | 92,677 |
| Profits Per Employee | 22,532 |
| Employee Count | 7,968 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 4.23 |
Taxes
In the past 12 months, KLSE:HSPLANT has paid 54.20 million in taxes.
| Income Tax | 54.20M |
| Effective Tax Rate | 23.19% |
Stock Price Statistics
The stock price has decreased by -3.32% in the last 52 weeks. The beta is -0.03, so KLSE:HSPLANT's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -3.32% |
| 50-Day Moving Average | 2.13 |
| 200-Day Moving Average | 1.97 |
| Relative Strength Index (RSI) | 36.49 |
| Average Volume (20 Days) | 389,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:HSPLANT had revenue of MYR 738.45 million and earned 179.53 million in profits. Earnings per share was 0.22.
| Revenue | 738.45M |
| Gross Profit | 293.23M |
| Operating Income | 236.78M |
| Pretax Income | 233.74M |
| Net Income | 179.53M |
| EBITDA | 296.95M |
| EBIT | 236.78M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 646.47 million in cash and 58.86 million in debt, giving a net cash position of 587.61 million or 0.73 per share.
| Cash & Cash Equivalents | 646.47M |
| Total Debt | 58.86M |
| Net Cash | 587.61M |
| Net Cash Per Share | 0.73 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 2.62 |
| Working Capital | 791.60M |
Cash Flow
In the last 12 months, operating cash flow was 253.93 million and capital expenditures -81.70 million, giving a free cash flow of 172.23 million.
| Operating Cash Flow | 253.93M |
| Capital Expenditures | -81.70M |
| Free Cash Flow | 172.23M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 39.71%, with operating and profit margins of 32.06% and 24.31%.
| Gross Margin | 39.71% |
| Operating Margin | 32.06% |
| Pretax Margin | 31.65% |
| Profit Margin | 24.31% |
| EBITDA Margin | 40.21% |
| EBIT Margin | 32.06% |
| FCF Margin | 23.32% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 6.10%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 6.10% |
| Dividend Growth (YoY) | 83.82% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 55.68% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.13% |
| Earnings Yield | 11.01% |
| FCF Yield | 10.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:HSPLANT has an Altman Z-Score of 3.85 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | 6 |